2-166196349-C-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001365536.1(SCN9A):​c.*2323G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00717 in 151,786 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0072 ( 14 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

SCN9A
NM_001365536.1 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, single submitter B:4

Conservation

PhyloP100: -1.51

Publications

1 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-166196349-C-A is Benign according to our data. Variant chr2-166196349-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 331911.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00717 (1089/151786) while in subpopulation SAS AF = 0.0525 (252/4802). AF 95% confidence interval is 0.0472. There are 14 homozygotes in GnomAd4. There are 567 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AD,SD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001365536.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN9A
NM_001365536.1
MANE Select
c.*2323G>T
3_prime_UTR
Exon 27 of 27NP_001352465.1Q15858-1
SCN9A
NM_002977.4
c.*2323G>T
3_prime_UTR
Exon 27 of 27NP_002968.2Q15858-3
SCN1A-AS1
NR_110260.1
n.432-3290C>A
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN9A
ENST00000642356.2
MANE Select
c.*2323G>T
3_prime_UTR
Exon 27 of 27ENSP00000495601.1Q15858-1
SCN9A
ENST00000303354.11
TSL:5
c.*2323G>T
3_prime_UTR
Exon 27 of 27ENSP00000304748.7Q15858-1
SCN9A
ENST00000409672.5
TSL:5
c.*2323G>T
3_prime_UTR
Exon 27 of 27ENSP00000386306.1Q15858-3

Frequencies

GnomAD3 genomes
AF:
0.00716
AC:
1086
AN:
151666
Hom.:
14
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00492
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00605
Gnomad ASJ
AF:
0.0493
Gnomad EAS
AF:
0.00906
Gnomad SAS
AF:
0.0522
Gnomad FIN
AF:
0.000476
Gnomad MID
AF:
0.0163
Gnomad NFE
AF:
0.00419
Gnomad OTH
AF:
0.0129
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.00717
AC:
1089
AN:
151786
Hom.:
14
Cov.:
32
AF XY:
0.00764
AC XY:
567
AN XY:
74198
show subpopulations
African (AFR)
AF:
0.00493
AC:
204
AN:
41366
American (AMR)
AF:
0.00604
AC:
92
AN:
15228
Ashkenazi Jewish (ASJ)
AF:
0.0493
AC:
171
AN:
3466
East Asian (EAS)
AF:
0.00908
AC:
47
AN:
5174
South Asian (SAS)
AF:
0.0525
AC:
252
AN:
4802
European-Finnish (FIN)
AF:
0.000476
AC:
5
AN:
10510
Middle Eastern (MID)
AF:
0.0176
AC:
5
AN:
284
European-Non Finnish (NFE)
AF:
0.00420
AC:
285
AN:
67934
Other (OTH)
AF:
0.0133
AC:
28
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
50
99
149
198
248
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00471
Hom.:
2
Bravo
AF:
0.00633
Asia WGS
AF:
0.0370
AC:
130
AN:
3464

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Channelopathy-associated congenital insensitivity to pain, autosomal recessive (1)
-
-
1
Paroxysmal extreme pain disorder (1)
-
-
1
Primary erythromelalgia (1)
-
-
1
Small fiber neuropathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.41
DANN
Benign
0.75
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142172527; hg19: chr2-167052859; API